- Home
- ELVN vs MFA Comparison
ELVN vs MFA Comparison
Compare ELVN & MFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVN
- MFA
- Stock Information
- Founded
- ELVN 2016
- MFA 1997
- Country
- ELVN United States
- MFA United States
- Employees
- ELVN N/A
- MFA 348
- Industry
- ELVN Biotechnology: Pharmaceutical Preparations
- MFA Real Estate Investment Trusts
- Sector
- ELVN Health Care
- MFA Real Estate
- Exchange
- ELVN Nasdaq
- MFA Nasdaq
- Market Cap
- ELVN 927.8M
- MFA 980.3M
- IPO Year
- ELVN 2020
- MFA N/A
- Fundamental
- Price
- ELVN $19.65
- MFA $9.52
- Analyst Decision
- ELVN Strong Buy
- MFA Buy
- Analyst Count
- ELVN 5
- MFA 6
- Target Price
- ELVN $39.60
- MFA $12.50
- AVG Volume (30 Days)
- ELVN 715.5K
- MFA 1.3M
- Earning Date
- ELVN 08-12-2025
- MFA 08-07-2025
- Dividend Yield
- ELVN N/A
- MFA 15.13%
- EPS Growth
- ELVN N/A
- MFA N/A
- EPS
- ELVN N/A
- MFA 0.99
- Revenue
- ELVN N/A
- MFA $292,245,000.00
- Revenue This Year
- ELVN N/A
- MFA N/A
- Revenue Next Year
- ELVN N/A
- MFA $14.73
- P/E Ratio
- ELVN N/A
- MFA $9.61
- Revenue Growth
- ELVN N/A
- MFA 52.95
- 52 Week Low
- ELVN $13.30
- MFA $7.85
- 52 Week High
- ELVN $30.03
- MFA $13.45
- Technical
- Relative Strength Index (RSI)
- ELVN 46.72
- MFA 45.38
- Support Level
- ELVN $20.22
- MFA $9.26
- Resistance Level
- ELVN $21.90
- MFA $9.73
- Average True Range (ATR)
- ELVN 1.55
- MFA 0.18
- MACD
- ELVN -0.24
- MFA -0.00
- Stochastic Oscillator
- ELVN 20.07
- MFA 30.00
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About MFA MFA Financial Inc.
MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company's reportable segments include mortgage-related assets and Lima One.